Pfizer’s Covid-19 drug a potential game changer
In the overall study population through Day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo
In the overall study population through Day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
Acute therapies continue to report strong growth compared to chronic ones.
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business
India reports 18 lakh stroke cases a year with 25 per cent patients below the age of 50
Subscribe To Our Newsletter & Stay Updated